A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy.

Trial Profile

A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 22 Mar 2012

At a glance

  • Drugs Satraplatin (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Sponsors GPC Biotech Inc
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Feb 2008 Status changed from recruiting to discontinued. Updated from ClinicalTrials.gov.
    • 10 Sep 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top